Cantillon Capital Management LLC Increases Position in Agilent Technologies, Inc. $A

Cantillon Capital Management LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 0.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 3,115,638 shares of the medical research company’s stock after acquiring an additional 23,493 shares during the quarter. Agilent Technologies comprises approximately 2.3% of Cantillon Capital Management LLC’s holdings, making the stock its 19th biggest position. Cantillon Capital Management LLC’s holdings in Agilent Technologies were worth $423,945,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Massachusetts Financial Services Co. MA boosted its stake in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after buying an additional 433,342 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Agilent Technologies by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after buying an additional 25,139 shares during the last quarter. Generation Investment Management LLP lifted its stake in Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after purchasing an additional 582,093 shares during the last quarter. Finally, Norges Bank purchased a new position in Agilent Technologies in the fourth quarter valued at approximately $549,158,000.

Wall Street Analyst Weigh In

Several equities analysts recently commented on A shares. Wells Fargo & Company dropped their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $161.71.

Agilent Technologies Trading Up 0.0%

Shares of A stock opened at $135.51 on Monday. The company’s fifty day simple moving average is $118.35 and its two-hundred day simple moving average is $128.24. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The stock has a market capitalization of $38.27 billion, a price-to-earnings ratio of 27.21, a PEG ratio of 2.41 and a beta of 1.26.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.99 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.